Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats

Minimal hepatic encephalopathy is more common than the acute syndrome. Losartan, the first angiotensin-II receptor blocker (ARB), and candesartan, another widely-used ARB, have protected against developing fibrogenesis, but there is no clear data about their curative antifibrotic effects. The curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Murad, H.A., Gazzaz, Z.J., Ali, S.S., Ibraheem, M.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609604/
https://www.ncbi.nlm.nih.gov/pubmed/28953991
http://dx.doi.org/10.1590/1414-431X20176665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609604/
https://www.ncbi.nlm.nih.gov/pubmed/28953991
http://dx.doi.org/10.1590/1414-431X20176665

Ejemplares similares